The director of the World Health Organization has confirmed that the first clinical trial of the coronavirus vaccine has already begun.
“Only 60 days after China shared the genetic sequence of the virus, this is an incredible achievement,” said Tedros Adhanom Gebreyesus.
Dr. Tedros praised the researchers from around the world who have come together to systematically evaluate experimental treatments.
“Multiple small trials with different methodologies may not give us the clear and strong evidence we need about which treatments help save lives. Therefore, WHO and its partners are organizing a study in many countries in which some of these unproven treatments will be compared with each other,” Tedros announced.
The international study, led by the Organization, is being conducted to generate solid data and demonstrate which treatments are the most effective.
“We have called this study the Solidarity Trial. This trial provides simplified treatments to allow even overburdened hospitals to participate,” he said.
Tedros confirmed the participation of several countries in the study: Argentina, Bahrain, Canada, France, Iran, Norway, South Africa, Spain, Switzerland and Thailand.
“I am confident that many more will join. I continue to be inspired by the many expressions of solidarity from around the world,” said the WHO chief.
So far, the COVID-19 Solidarity Response Fund has raised more than 43 million from over 173,000 individuals and organizations, just days after its launch.
“These and other efforts give me hope that together we can and will prevail. This virus presents us with an unprecedented threat. But it is also an unprecedented opportunity to unite as one against a common enemy – an enemy against humanity,” Tedros said.